Font Size

SCREEN

Profile

Direction

Menu Style

In Brief
  1. ISIRV Journal: IRV Journal impact factor is now 4.4
  2. OPTIONS XII 29 Sept-2 Oct 2024 Brisbane, Australia
OPTIONS for the Control of Influenza XII

Aeron Hurt, WHO Influenza Collaborating Centre, Australia (2)

Aeron photo

Aeron Hurt
WHO Influenza Collaborating Centre, Melbourne, Australia

Dr. Hurt has been a research scientist for the WHO Collaborating Centre for Reference and Research on Influenza, Melbourne, Australia for over 10 years and during this time has been involved with many aspects of influenza virus analysis and research.

The majority of Aeron’s research has focused on antiviral resistance to influenza, and in particular resistance to the neuraminidase inhibitor class of drugs, much of which has focused on the impact of key amino acid mutations on NA inhibitor resistance and their role in viral fitness using both in vitro and in vivo models.

Aeron is also a member of the Australian Influenza Specialist Group Scientific Committee.